Mercer Global Advisors Inc. ADV boosted its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 21.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 623,529 shares of the semiconductor company's stock after purchasing an additional 108,615 shares during the period. Mercer Global Advisors Inc. ADV's holdings in Lam Research were worth $83,491,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Howard Hughes Medical Institute acquired a new stake in Lam Research in the 2nd quarter valued at about $27,000. Strategic Wealth Investment Group LLC purchased a new position in Lam Research during the 2nd quarter valued at about $29,000. Delos Wealth Advisors LLC acquired a new position in Lam Research during the second quarter worth about $30,000. Country Trust Bank acquired a new position in Lam Research during the second quarter worth about $39,000. Finally, Sound Income Strategies LLC purchased a new stake in shares of Lam Research in the third quarter valued at about $41,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Stock Performance
NASDAQ:LRCX opened at $219.40 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The firm has a market cap of $273.98 billion, a PE ratio of 44.96, a P/E/G ratio of 2.28 and a beta of 1.77. The firm has a 50 day simple moving average of $225.24 and a 200-day simple moving average of $174.48. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research's revenue was up 22.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.
Lam Research Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research's dividend payout ratio (DPR) is 21.31%.
Insider Activity
In related news, CFO Douglas R. Bettinger sold 50,057 shares of the company's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ava Harter sold 1,500 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total value of $333,990.00. Following the transaction, the insider owned 53,205 shares in the company, valued at $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 130,886 shares of company stock valued at $29,658,802 over the last quarter. Company insiders own 0.31% of the company's stock.
Analyst Ratings Changes
LRCX has been the topic of several research reports. TD Cowen increased their price target on shares of Lam Research from $170.00 to $290.00 and gave the company a "buy" rating in a research report on Thursday, January 29th. Susquehanna set a $325.00 target price on Lam Research and gave the company a "positive" rating in a research note on Thursday, January 29th. B. Riley Financial reiterated a "buy" rating on shares of Lam Research in a report on Thursday, January 15th. Barclays raised their price target on Lam Research from $250.00 to $255.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 10th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $320.00 price target (up from $265.00) on shares of Lam Research in a report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Lam Research has an average rating of "Moderate Buy" and a consensus price target of $245.35.
Check Out Our Latest Stock Report on LRCX
About Lam Research
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.